Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cyberonics to carry on without CCO after James Reinstein resigns

This article was originally published in Clinica

Executive Summary

James Reinstein has resigned as Cyberonics' senior vice-president and chief commercial officer due to personal reasons, and the vagal nerve stimulation specialist has decided not to replace him. Mr Reinstein will leave the company on 27 April 2012, at the end of its current fiscal year; until then he will help transfer his responsibilities to other Cyberonics' employees. This includes Mark Verratti, who was recently appointed vice-president of sales in the Americas, Asia and EMMEA (Eastern Mediterranean, Middle East and Africa), and will continue in this role.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT097991

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel